Seattle, WASHINGTON3 Active Studies

Hemophilia Clinical Trials in Seattle, WASHINGTON

Find 3 actively recruiting hemophilia clinical trials in Seattle, WASHINGTON. Connect with local research sites and explore new treatment options.

3
Active Trials
2
Sponsors
532
Enrolling

Recruiting Hemophilia Studies in Seattle

About Hemophilia Clinical Trials in Seattle

Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.

There are currently 3 hemophilia clinical trials recruiting participants in Seattle, WASHINGTON. These studies are seeking a combined 532 participants. Research is being sponsored by Pfizer, Be Biopharma. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hemophilia Clinical Trials in Seattle — FAQ

Are there hemophilia clinical trials in Seattle?

Yes, there are 3 hemophilia clinical trials currently recruiting in Seattle, WASHINGTON. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Seattle?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Seattle research site will contact you about next steps.

Are clinical trials in Seattle free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Seattle studies also compensate for your time and travel.

What hemophilia treatments are being tested?

The 3 active trials in Seattle are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.

Data updated March 2, 2026 from ClinicalTrials.gov